JPWO2024010592A5 - - Google Patents

Info

Publication number
JPWO2024010592A5
JPWO2024010592A5 JP2025524504A JP2025524504A JPWO2024010592A5 JP WO2024010592 A5 JPWO2024010592 A5 JP WO2024010592A5 JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025524504 A JP2025524504 A JP 2025524504A JP WO2024010592 A5 JPWO2024010592 A5 JP WO2024010592A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
amount ranging
present
alprazolam
ebastine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025524504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025522146A5 (https=
JP2025522146A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/036579 external-priority patent/WO2024010592A1/en
Publication of JP2025522146A publication Critical patent/JP2025522146A/ja
Publication of JPWO2024010592A5 publication Critical patent/JPWO2024010592A5/ja
Publication of JP2025522146A5 publication Critical patent/JP2025522146A5/ja
Pending legal-status Critical Current

Links

JP2025524504A 2022-07-08 2022-07-08 不眠症を治療するための医薬組成物および方法 Pending JP2025522146A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2022/036579 WO2024010592A1 (en) 2022-07-08 2022-07-08 Pharmaceutical compositions and methods for treating insomnia

Publications (3)

Publication Number Publication Date
JP2025522146A JP2025522146A (ja) 2025-07-10
JPWO2024010592A5 true JPWO2024010592A5 (https=) 2025-07-17
JP2025522146A5 JP2025522146A5 (https=) 2025-07-17

Family

ID=89453886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025524504A Pending JP2025522146A (ja) 2022-07-08 2022-07-08 不眠症を治療するための医薬組成物および方法

Country Status (7)

Country Link
US (1) US20250205218A1 (https=)
EP (1) EP4551220A1 (https=)
JP (1) JP2025522146A (https=)
CN (1) CN119255803A (https=)
AU (1) AU2022468585A1 (https=)
CA (1) CA3261198A1 (https=)
WO (1) WO2024010592A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12370198B2 (en) 2022-07-08 2025-07-29 La Pharmatech Inc Pharmaceutical compositions and methods for treating psychiatric disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10898493B2 (en) * 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
WO2021005189A1 (fr) * 2019-07-09 2021-01-14 Universite De Bretagne Occidentale (Ubo) Nouveaux composés inhibiteurs de la pfar

Similar Documents

Publication Publication Date Title
JP2023109969A5 (https=)
JP2021527092A5 (https=)
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
JP2020522560A5 (https=)
KR20110112279A (ko) 의약품 및 치료
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
JP7123205B2 (ja) 経口用医薬組成物
JPWO2024010592A5 (https=)
JP5296968B2 (ja) イブプロフェン含有経口用医薬組成物
Shen et al. Clinical Impact of Root Canal Treatment Combined With Eugenol Cement on Acute Pulpitis and Its Influence on Inflammatory Factor Levels
JP2021530568A5 (https=)
CN104000814B (zh) 一种防治痛风性关节炎的药物组合物及其用途
CN108371712B (zh) 咖啡因与PPARγ激动剂联合制备AD药物中的用途
JP6940265B2 (ja) 止瀉剤組成物
JPWO2023043999A5 (https=)
RU2837138C1 (ru) Способ лечения орального кандидоза у пациентов в постковидный период
CN110721310A (zh) 一种药物组合物在制备治疗急性出血性脑损伤的应用
Raja et al. Effect of preoperative medications on the efficacy of inferior alveolar nerve block in patients with irreversible pulpitis: A placebo-controlled clinical study
JP4993998B2 (ja) イブプロフェンを含有する医薬組成物
CN106177382A (zh) 治疗口腔溃疡的药物组合物、其制备方法及制剂
JPWO2022101395A5 (https=)
Das et al. A brief review of muco-protective agent in the treatment of recurrent aphthous ulcer and behcet’s syndrome: Rebamipide
RU2025132881A (ru) Лечение псориаза с применением низкомолекулярного ингибитора фактора некроза опухоли альфа
Levin et al. Therapeutic trials in acute gouty arthritis
RU2039566C1 (ru) Способ лечения воспалительных и дистрофических заболеваний слизистых оболочек органов пищеварения